Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Transform your holiday decor with a charming cardboard Christmas tree. This step-by-step guide walks you through creating a festive masterpiece that adds a personal touch to your celebrations. Perfect ...

Photoshop tutorial showing how to make natural-looking sunbeams filtering through forest trees. ‘We are looking at a massive crisis’ Men’s lazy habit fueling millennial "dating crisis" revealed 4th ...

Many of the best artificial Christmas trees are on sale for Cyber Week, including our best overall pick, the National Tree Company Douglas Fir. For more deals, check out our roundup of the best Cyber ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

If you’re staring at a bare Christmas tree and a tight budget, you’re not alone. Surveys this year show nearly a third of people are spending less on holiday decorations, mostly to save money, and ...

Steve Nix is a member of the Society of American Foresters and a former forest resources analyst for the state of Alabama. According to National Wildlife Federation, there are two varieties of Douglas ...